EXSCIENTIA PLC (EXAI)

US30223G1022 - ADR

4.03  +0.04 (+1%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to EXAI. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.84. This target is 119.36% above the current price.
EXAI was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about EXAI.
In the previous month the buy percentage consensus was at a similar level.
EXAI was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

Price Target & Forecast

Price Low Median Mean High 4.037.079.188.8410.50 - 75.43% 127.79% 119.36% 160.55%

Related screens

Up and Down Grades
Date Firm Action Rating
2024-04-22 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-01-05 B of A Securities Downgrade Buy -> Neutral
2023-10-17 Barclays Maintains Overweight -> Overweight
2023-10-11 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-08-01 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-07-31 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-07-24 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-07-21 Berenberg Initiate Buy
2023-07-20 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-07-17 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-06-26 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-06-20 Morgan Stanley Reiterate Equal-Weight
2023-06-12 Morgan Stanley Reiterate Equal-Weight
2023-04-10 Morgan Stanley Maintains Equal-Weight
2022-11-16 Barclays Maintains Overweight
2022-09-09 Morgan Stanley Maintains Equal-Weight
2022-08-24 Morgan Stanley Maintains Equal-Weight
2022-06-13 Morgan Stanley Maintains Equal-Weight
2022-05-24 Goldman Sachs Maintains Buy
2022-04-11 Morgan Stanley Maintains Equal-Weight
2021-10-26 Goldman Sachs Initiate Buy
2021-10-26 B of A Securities Initiate Buy
2021-10-26 Morgan Stanley Initiate Equal-Weight